Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate...

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Biology

Background:

• Estrogen receptor alpha (ERalpha) is crucial for lactotroph homeostasis, even without estrogen (E2).
• Anti-estrogens like ICI 182780 (ICI) induce ERalpha degradation and inhibit cell proliferation, while suppressing prolactin (PRL) release.
• Tamoxifen and raloxifene suppress PRL release but do not promote ERalpha degradation.

Purpose of the Study:

• To investigate whether ERalpha degradation versus occupation differentially modulates biological outcomes of anti-estrogens.
• To clarify the distinct roles of ERalpha degradation and occupation in lactotroph function.

Main Methods:

• Utilized the rat lactotroph cell line, GH3 cells.
• Compared the effects of ICI 182780 (ICI) and an ERalpha-specific antagonist, MPP, which does not induce ERalpha degradation.
• Assessed proteasome-mediated degradation, cell proliferation, anchorage-independent growth, PRL expression and release, and ERE-mediated transcriptional activity.

Main Results:

• ICI induced proteasome-mediated degradation of ERalpha in GH3 cells.
• MPP did not inhibit cell proliferation or abolish anchorage-independent growth.
• Both ICI and MPP equally suppressed PRL expression and release, and ERE-mediated transcriptional activity.

Conclusions:

• ERalpha degradation in lactotrophs leads to reduced cell proliferation.
• ERalpha occupation by antagonists that do not induce degradation is sufficient to inhibit PRL expression.
• Distinct mechanisms of ERalpha modulation yield different biological outcomes in lactotrophs.